crB ((r37) is a secondary species of RNA polymerase sigma factor found in the gram-positive bacterium Bacillus subtilis. To study the function of (rB genetically, we sought mutations that block the expression of a gene (ctc) known to be transcribed by B-containing RNA polymerase in vitro. One such mutation, called crl, was found to map in or near the structural gene (sigB) for (yB. To determine directly whether mutations in sigB would prevent transcription of ctc, we replaced sigB in the B. subtilis chromosome with insertion and deletion mutations that disrupted the cJB coding sequence. Like crl, these in vitro-constructed mutations blocked expression of ctc, but had little or no effect on viability, sporulation, expression of the sporulation gene spoVG, or production of sporulation-associated alkaline protease. Using fusions of ctc to the reporter genes xylE and lacZ, we also identified mutations that enhanced ctc expression. One such mutation, called socB, was found to be located in an open reading frame immediately downstream of sigB.
The DNA-dependent RNA polymerase of the grampositive bacterium Bacillus subtilis is a highly heterogenous enzyme that exists in several different holoenzyme forms (4, 13) . Each form of holoenzyme consists of core RNA polymerase and one of several different species of sigma factor that confers on the core enzyme the capacity to recognize and initiate transcription from a particular class of promoters. We have been interested in a secondary species of sigma factor called aB (formerly J7; 9, 10) . This 29.9-kilodalton polypeptide (1, 7) , which is found in vegetative and earlystationary-phase cells, directs the transcription in vitro of certain genes that are activated at the end of the exponential phase of growth (9) (10) (11) (12) . However, little is known about the contribution of arB to the expression of these genes in vivo or its role in B. subtilis gene expression. The recent identification of the structural gene for crJB (sigB; 1, 7) and the availability of plasmid and bacteriophage vectors bearing fusions of genes transcribed in vitro by cB_containing RNA polymerase to the reporter genes cat, xylE, and lacZ (11, 17, 21) have made it possible to study the function of this minor sigma factor genetically. In this paper we describe the identification and characterization of mutations in and near sigB that enhance or inhibit the expression of a B. subtilis gene, ctc, which is known to be actively transcribed by aB-containing RNA polymerase in vitro. One such mutation that significantly stimulates ctc transcription was found to be located in an open reading frame immediately adjacent to and downstream from sigB. We also describe the construction of insertion and deletion mutations in sigB and report, in confirmation and extension of previous work (1, 7) , that they have little or no effect on cell viability, sporulation, or sporulation-associated gene expression.
MATERIALS AND METHODS
Bacterial strains, phages, and plasmids. Bacterial strains used in this study are listed in Table 1 . Plasmids pCR15, * Corresponding author. pML7, and pML11 are described in references 1 and 17. Phage SPIctc-lacZ is described in reference 11.
Preparation of DNA. Plasmid DNA was isolated by the alkaline lysis procedure of Birnboim and Doly (2) and then purified by centrifugation through a cesium chloride gradient (14) . B. subtilis chromosomal DNA was isolated by the procedure of Marmur (15) as modified by P. Youngman (personal communication).
Transformation in B. subtilis. B. subtilis competent cells were prepared and transformed as described by Dubnau and Davidoff-Abelson (6) .
Construction of deletion and insertion mutations in sigB. To create the deletion mutation sigB::AHindIII-EcoRV::cat, we first eliminated the HindIIl site in pUC9 by filling in the sticky ends of the restriction site with the Klenow fragment of DNA polymerase I and ligating the blunt ends to generate pML18. The 1.7-kilobase (kb) sigB-containing PstI fragment from pML7 was then ligated into the PstI site in pML18, creating plasmid pML16. pML16 was digested with HindIII and EcoRV, and the deleted HindIII-EcoRV segment was replaced by a 1.5-kb SmaI cat fragment from pMI1101. The resulting plasmid, pML19, was used to transform Escherichia coli cells to ampicillin and chloramphenicol resistance. Restriction enzyme analysis of pML19 from one such transformant confirmed that the HindIII-EcoRV segment of sigB in the plasmid had been replaced with the 1.5-kb cat insertion. The sigB: :AHindIII-EcoRV: :cat mutation was then transferred from pML19 into the B. subtilis chromosome by transforming competent cells of strain 168 to chloramphenicol resistance with the linearized plasmid DNA to create strain ML6. Similarly, the sigB: :cat insertion mutant was created by insertion of the 1.5-kb cat-containing SmaI fragment of pMI1101 into the EcoRV site of plasmid pML11 to create pML14. This sigB::cat mutation was transferred from pML14 to the B. subtilis chromosome by transformation of competent cells with linearized plasmid DNA to create strain ML1.
Construction of isogenic strains containing mutations that affect ctc-lacZ expression. The first step in the constuction of Assay of P-galactosidase activity. B. subtilis cells containing the ctc-lacZ fusion were grown in the presence of chloramphenicol in LB medium or in LB medium supplemented with 5% glucose and 0.2% glutamine (11) . After the cultures reached a reading of 70 Klett units, 1-ml samples were removed from the culture at the indicated times and were stored overnight at -70°C. The cells were harvested by centrifugation and were suspended in Z buffer (16) , permeabilized (5), and assayed for 1-galactosidase activity by the method of Miller (16) .
Sequence analysis of the socB mutation. Chromosomal DNA from the socB mutant, EU100, and from the parental strain, JH642, was cleaved with PstI, and DNA fragments in the size range of 1.4 to 2 kb were partially purified by electrophoresis into a 0.8% agarose gel. These fragments were ligated to pUC18 that had been cleaved with PstI and treated with calf intestine phosphatase. This ligation mixture was used to transform E. coli HE101 to ampicillin resistance, and sigB-containing recombinants were identified by colony blot hybridization by using the radioactively labeled (8) sigB-containing plasmid pML11 as a probe.
The nucleotide sequence of nucleotides between the promoter-proximal HindIll site within sigB and the PstI site in orfx of the DNA fragment isolated from the socB mutant was determined by the dideoxynucleotide sequencing method of Sanger et al. (18) after the fQllowing fragments of this region were subcloned into phages M13mp18 and M13mp19: (i) the 93-base-pair (bp) Hindlll fragment; (ii) the 174-bp region between the promoter-distal HindlIl site and the EcoRI site; (iii) the 540-bp region between the EcoRI site and the PstI site in orfx; (iv) the region between the promoter-distal Hindlll site and the EcoRV site located 295 bp downstream; (v) the region between the EcoRV site and the StuI site located 210 bp downstreamn from the EcoRV site; (vi) the 204-bp region between the Stul site and the PstI site in orfx; and (vii) the 710-bp region between the promoter-distal HindIII site and the PstI site in orfX. The sequence of each region was determined by using both strands as templates.
RESULTS
Identification of a mutation blocking the expression of a gene transcribed by Eo-B. Our strategy for identifying mutations that altered orB was to isolate mutants affecting the expression of a gene whose promoter is used by a B_ containing RNA polymerase in vitro. For these experiments, we took advantage of a previously described specialized transducing phage SPpc2del-2: :Tn9J 7cat-J11:: ctc-lacZ (henceforth called SPPctc-lacZ) bearing an in-frame fusion of the EaB-transcribed B. subtilis gene ctc to the lacZ gene of E. coli (11) . Transcription of the ctc gene is strongly induced at the end of the exponential phase of growth under conditions in which the activity of the tricarboxylic acid (TCA) cycle is inhibited (11) . This induction can be monitored conveniently by following the synthesis of ,Bgalactosidase in cells containing the SPpctc-lacZ fusionbearing transducing phage.
As a first step in our analysis, we used SPpctc-lacZ to introduce the gene fusion by specialized transduction into a variety of laboratory strains of B. subtilis. During these experiments, we unexpectedly discovered that one strain, YB886 (trpC2 metB5 xin-J SPiS; obtained from R. Yasbin, University of Rochester), was unable to support ctc-directed 3-galactosidase synthesis. Genetic mapping experiments revealed that the mutation in YB886 responsible for blocking ctc expression was located in close proximity to the structural gene for or3, sigB. Like sigB, the mutation in YB886 (designated crl) was approximately 80% linked in DNA- VOL. 169, 1987 mediated transformation experiments to a mutation that causes D-alanine auxotrophy, dal-I. Also, the crl mutation could be corrected by transformation of YB886 with plasmid DNA (pML11; Fig. 1 ) containing the sigB gene (data not shown).
To investigate the effect of crl on the pattern of ctcdirected 3-galactosidase synthesis, we took advantage of the high linkage of crl to dal-J to construct a pair of otherwise isogenic strains containing or lacking the crl mutation. Figure 2 compares the expression of the prophage-borne ctc-lacZ fusion in these two strains under conditions that were either strongly inducing (LB medium containing added glucose and glutamine to inhibit the tricarboxylic acid cycle) or weakly inducing (LB medium) for ctc expression. Under both conditions, the crl mutation caused almost a complete block in ctc-directed synthesis of ,B-galactosidase.
Construction of a sigB insertion mutation. The close proximity of crl to sigB led us to suspect that a mutation in the cB structural gene was responsible for the block in ctc-lacZ expression. To investigate directly whether a mutation in sigB would prevent ctc expression, we took advantage of a previously constructed insertion mutation within the cB coding sequence, which was created by cloning a 1.5-kb fragment of DNA containing a chloramphenicol resistance gene (cat) into a unique EcoRV site in sigB (Fig. 1) . We then replaced the wild-type sigB gene in the B. subtilis chromosome with the insertionally inactivated gene by transforming competent cells with linear DNA bearing the sigB: :cat mutation and selecting for chloramphenicol-resistant transformants. Southern hybridization analysis of genomic DNA from one such transformant verified that the resident B. subtilis sigB gene had been substituted by the in vitroconstructed sigB: :cat insertionally mutated gene (not shown). In addition, RNA polymerase purification experiments verified that the sigB insertion mutation resulted in the absence of EurB holoenzyme (L. Carter and C. P. Moran, Jr., unpublished results).
The effect of the in vitro-constructed insertion mutation on the ctc-directed synthesis of P-galactosidase is shown in Fig.   2 . Like the naturally occurring crl mutation, the in vitroconstructed sigB::cat mutation caused a severe block in ctc-directed synthesis of ,-galactosidase. Surprisingly, however, neither the crl mutant nor the sigB insertion mutant was defective in growth or sporulation, in the induction of the sporulation gene spoVG, or in the synthesis of the sporulation-associated enzyme alkaline protease (Materials and Methods and data not shown). It remained possible, however, that the sigB::cat insertion mutation was not a true null mutation and that the insertion of DNA at the EcoRV site in the 3' half of the gene permitted the synthesis of a truncated sigma protein that could not be detected in vitro, but was nonetheless capable of carrying out some of the functions of uB in vivo. To eliminate this possibility, we constructed a deletion mutation of sigB in which the DNA between the 5'-proximal HindIll site and the EcoRV site in the 3' half of the gene was removed (thereby eliminating almost half of the coding sequence; Fig. 1 ) and replaced the deleted HindIII-EcoRV DNA segment with a cat-bearing DNA fragment. We then substituted the chromosomal sigB gene with sigBAHindIII-EcoRV::cat deletionmutated gene by transforming competent cells with linearized plasmid DNA, which contained the in vitro-constructed mutation, and selecting for chloramphenicol-resistant transformants. (As above, the introduction of the deletion mutation into the chromosome was verified by Southern hybridization analysis.) Like the original sigB::cat insertion mutation, the sigBAHindIII-EcoRV::cat deletion mutation blocked ctc expression, but had no effect on cell viability, sporulation or spoVG-lacZ expression.
Isolation of mutations enhancing the transcription of ctclacZ. As another approach to studying a&, we sought mutants in which the expression of Ctc was enhanced. In these experiments we used both the SPfctc-lacZ transducing phage described above and a previously described plasmid vector (designated pCR15) bearing a transcriptional fusion of a ctc promoter mutation to the xylE gene of Pseudomonas putida (17 (Fig. 2) . Further study revealed that the copB mutant was not defective in growth or sporulation or in the expression of spoVG, but that the socB mutant produced uniformly small colonies and was mildly defective in sporulation.
Fine-structure mapping of the socB mutation. Next, we wished to determine the position of the socB and copB mutations relative to the &rB coding sequence by testing various segments of cloned DNA from the sigB region of the chromosome for their ability to correct socB and copB by means of DNA-mediated transformation. Unfortunately, the dark-blue colony color on X-Gal indicator plates of mutant cells bearing the ctc-lacZ fusion varied too much from colony to colony to be used directly in such fine-structure mapping experiments. The small colony phenotype of the socB mutant, however, was sufficiently distinctive and uniform that we could reliably identify socB+ transformants even at very low frequencies. To enrich for cells that had undergone transformation, we used a congression procedure in which competent cells of a strain carrying the socB mutation, the SP3ctc-lacZ prophage, and a trp auxotrophy mutation were transformed with a mixture of plasmid DNA containing sigB sequences and limiting amounts of chromosomal DNA from a trp+ socB strain. We then selected for Trp+ prototrophy and screened the transformants for the ability to produce normal-sized colonies (which we infer to be socB+ transformants). Plasmid pML7, which contained the entire sigB gene and flanking DNA (Fig. 1) , displayed substantial transforming activity for the socB mutation (Table 2). The socB mutation could also be corrected by transformation with the plasmid subclones pML11 and pML12 (Table 2) . From the 0.7-kb region of sequence overlap in pML11 and pML12 (Fig. 1) 7). Because all the socB+ transformants obtained by transformation with pML7, pML11, and pML12 yielded light-blue colonies when tested for ctc-lacZ expression of X-Gal plates, we further conclude that the small colony phenotype and the enhanced expression of ctc are due to the same or very closely linked mutations.
To determine whether socB lay within sigB or in the adjacent orfX gene, we cloned the 0.7-kb HindIII-PstI segment from a socB mutant and determined the location of the socB mutation directly by DNA sequence analysis. The 0.7-kb fragment was divided into six overlapping segments, and each was cloned into phages M13mp19 and M13mp18, so that the nucleotide sequence could be determined for both a The capacity of cloned DNA to restore a SocB + phenotype (large colony size) to a strain that carries the socB mutation was examined by using a congression transformation protocol. In these experiments, competent B. subtilis cells (IM40) were transformed with 10 ng of trp+ socB chromosomal DNA (IM42) and 2 jg of the indicated plasmids, whose DNA inserts are described in Fig. 1 . Trp+ transformants were selected by their ability to grow on minumal medium and then screened for large colony size. The large colonies were then examined on X-Gal indicator plates to determine whether they produced wild-type levels of P-galactosidase.
strands. This analysis showed that the nucleotide sequence of the socB mutant DNA in the 700-bp interval from the HindIII site to the PstI site differed from the published nucleotide sequence of the wild-type site at only a single position: the absence of an A T base pair in a stretch of seven consecutive A T base pairs located approximately 80 bp upstream of the PstI (positions 1478 to 1484 in reference 7). The socB mutation would therefore appear to be a single-base-pair deletion mutation located outside of the cB coding sequence, which causes a frameshift mutation in the downstream open reading frame, oriX. As a control, we cloned the 0.7-kb HindIII-PstI DNA from the parent strain (JH642) of the socB mutant and verified the presence of seven consecutive A T base pairs at the position of six consecutive A . T base pairs in DNA from the socB mutant. Figure 3 shows a comparison of the products of the DNA sequencing reactions for the region containing the stretch of A T base pairs from the wild-type and the socB mutant.
DISCUSSION
We have described three different mutations in or near the structural gene for aB that block the expresion of ctc, a gene that is known to be transcribed efficiently by aB-containing RNA polymerase in vitro. One of these mutations, crl, was discovered in a laboratory strain of B. subtilis and is probably a simple loss-of-function mutation of aB. Our mapping experiments did not, however, distinguish whether crl is actually in sigB or simply near it. In addition to the crl mutation, two in vitro-constructed mutations (sigB::cat and sigB::AHindII1-EcoRV::cat) that are located within the uB_ coding sequence also blocked the transcription of ctc. Taken together with results of earlier studies demonstrating a close correlation between sequences required for recognition of the ctc promoter by EaB in vitro (19, 20) and for the utilization of the ctc promoter in vivo (11, 17) , the existence of these mutations provides strong genetic evidence that transcription of ctc in vivo is determined by the E.B form of RNA polymerase holoenzyme.
Using plasmid and phage vectors bearing fusions of ctc to xylE and lacZ, we also identified two mutations, called socB and copB, that caused increased ctc expression and that mapped near sigB. Surprisingly, DNA sequence analysis of one of these mutations (socB) revealed that the mutation did In confirmation and extension of earlier work (1, 7), we have found that insertion of 1.5 kb of DNA into the EcoRV site of sigB has no effect on the viability of B. subtilis or its capacity to sporulate. In addition, the EcoRV mutation did not affect the production of sporulation-associated alkaline protease or expression of the sporulation gene spoVG. However, because insertion at the EcoRV site left intact more than 70% of the aB coding sequence, it remnained possible that crB function was not entirely elimirnated in these in vitro-constructed mutations. As a more definitive demonstration that sigB is nonessential for growth or sporulation, we constructed a mutation (sigB&HindIII-EcoRV::cat) that eliminated DNA between the upstream HindIl site and the EcoRV site in sigB and that substituted this internal stretch of coding sequence with a 1.5-kb fragment of foreign DNA. This deletion mutation left intact less than 20% of the sigB gene. Like the simple insertion mutations, sigBAHindIIIEcoRV::cat did not affect growth, sporulation, or expression of spoVG.
The finding that spoVG transcription was not blocked by these insertion and deletion mutations in sigB was unexpected, because the EaB holoenzyme form was actually discovered by using spoVG DNA as a template in in vitro transcription experiments (9) . Recently, Carter and Moran (3) discovered an additional secondary holoenzyme form, called Ec30, that also uses the spoVG promoter in vitro. Ecr30 is distinct from EuB, because it is present in cells carrying a sigB insertion mutation. Recent evidence (J. Weir, E. Dubnau, I. Smith, L. Carter, and C. Moran, Jr., unpublished results) suggests that cr30 iS the product of spoOH, a transcriptional regulatory gene whose product is required for spoVG expression in vivo (22, 23 ; P. Zuber, J. Healy, and R.
Losick, unpublished re$ults). The finding that (uB is not required for spoVG expression uinderscores the importance of having genetic criteria for evaluating the contribution of various minor holoenzyme forms to the expression of individual genes in vivo. Given that cB is not required for growth or sporulation, we are left in a quandary as to the function of the EaB holoenzyme form. It will be interesting to see what effect, if any, our in vitro-constructed sigB mutations have on other aspects of B. subtilis physiology and on the expression of other genes that have been found to be transcribed by EoB in vitro.
